Locations:
Search
Pinpointing how tumors reprogram platelets and trigger blood clots
Approach resulted in transfusion independence and durable anemia response
Challenges emerge with application of interim PET scans
Combination therapy demonstrates effectiveness in first-line treatment setting
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Unique molecular features found in young-onset disease
Satellitosis or in-transit metastasis is a rare yet significant risk factor for this skin cancer that should be reflected in clinical staging systems.
Optimized models can personalize predictions for patients with prostate, breast and other cancers
Treatment addresses endocrine resistance
Lack of appropriate testing remains a barrier for patients eligible for targeted treatment
Fine-tuning radiation for recurrent cancers
Advertisement
Advertisement